Declaration of competing financial interests
From the following article:
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Lars Bertram & Rudolph E. Tanzi
Nature Reviews Neuroscience 9, 768-778 (October 2008)
doi:10.1038/nrn2494
Declaration: Lars Bertram and Rudolph E. Tanzi
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nature Reviews Neuroscience9, 768–778 (2008); doi:10.1038/nrn2494
Rudolph Tanzi and Lars Bertram are both consultants to, and equity holders in, TorreyPines Therapeutics, Inc. Rudolph Tanzi is a consultant to, and an equity holder in, Prana Biotechnology, Limited. Rudolph Tanzi is a co-founder of both TorreyPines Therapeutics and Prana Biotechnology.
